<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37697342</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Research progress on the role of extracellular vesicles in neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>43</StartPage><MedlinePgn>43</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">43</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-023-00375-9</ELocationID><Abstract><AbstractText>Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease, affect millions of people worldwide. Tremendous efforts have been put into disease-related research, but few breakthroughs have been made in diagnostic and therapeutic approaches. Extracellular vesicles (EVs) are heterogeneous cell-derived membrane structures that arise from the endosomal system or are directly separated from the plasma membrane. EVs contain many biomolecules, including proteins, nucleic acids, and lipids, which can be transferred between different cells, tissues, or organs, thereby regulating cross-organ communication between cells during normal and pathological processes. Recently, EVs have been shown to participate in various aspects of neurodegenerative diseases. Abnormal secretion and levels of EVs are closely related to the pathogenesis of neurodegenerative diseases and contribute to disease progression. Numerous studies have proposed EVs as therapeutic targets or biomarkers for neurodegenerative diseases. In this review, we summarize and discuss the advanced research progress on EVs in the pathological processes of several neurodegenerative diseases. Moreover, we outline the latest research on the roles of EVs in neurodegenerative diseases and their therapeutic potential for the diseases.</AbstractText><CopyrightInformation>&#xa9; 2023. Ruijin Hospital, Shanghai Jiao Tong University.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Zhengzhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Xiaoling</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaoxing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Xiaomei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Yin Kwan</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Shenzhen Key Laboratory of Kidney Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, 518020, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jiyang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Die</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jigang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China. jgwang@icmm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Shenzhen Key Laboratory of Kidney Diseases, and Shenzhen Clinical Research Centre for Geriatrics, Shenzhen People's Hospital, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen, 518020, China. jgwang@icmm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. jgwang@icmm.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China. jgwang@icmm.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Tianyu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1934-0032</Identifier><AffiliationInfo><Affiliation>The First School of Clinical Medicine, Gannan Medical University, Ganzhou, 341000, China. zhongtianyu@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, China. zhongtianyu@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Central nervous system</Keyword><Keyword MajorTopicYN="N">Extracellular vesicle</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">Pathogenesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>11</Day><Hour>23</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37697342</ArticleId><ArticleId IdType="pmc">PMC10494410</ArticleId><ArticleId IdType="doi">10.1186/s40035-023-00375-9</ArticleId><ArticleId IdType="pii">10.1186/s40035-023-00375-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27&#x2013;68. doi: 10.1146/annurev-biochem-061516-045115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-061516-045115</ArticleId><ArticleId IdType="pubmed">28498720</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudou F, Humbert S. The biology of huntingtin. Neuron. 2016;89:910&#x2013;926. doi: 10.1016/j.neuron.2016.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.02.003</ArticleId><ArticleId IdType="pubmed">26938440</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb Perspect Biol. 2017;9:e028035. doi: 10.1101/cshperspect.a028035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a028035</ArticleId><ArticleId IdType="pmc">PMC5495060</ArticleId><ArticleId IdType="pubmed">28062563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112&#x2013;2117. doi: 10.1016/S0140-6736(05)67889-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)67889-0</ArticleId><ArticleId IdType="pmc">PMC2850264</ArticleId><ArticleId IdType="pubmed">16360788</ArticleId></ArticleIdList></Reference><Reference><Citation>Poste G. Bring on the biomarkers. Nature. 2011;469:156&#x2013;157. doi: 10.1038/469156a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/469156a</ArticleId><ArticleId IdType="pubmed">21228852</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrocki P, Khatun A, Ness D, Senkevich K, Hanrieder J, Capraro F, et al. Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg. Alzheimers Res Ther. 2020;12:20. doi: 10.1186/s13195-020-00586-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00586-6</ArticleId><ArticleId IdType="pmc">PMC7049194</ArticleId><ArticleId IdType="pubmed">32111242</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlyle BC, Trombetta BA, Arnold SE. Proteomic approaches for the discovery of biofluid biomarkers of neurodegenerative dementias. Proteomes. 2018;6:32. doi: 10.3390/proteomes6030032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/proteomes6030032</ArticleId><ArticleId IdType="pmc">PMC6161166</ArticleId><ArticleId IdType="pubmed">30200280</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K, Zetterberg H. Understanding biomarkers of neurodegeneration: ultrasensitive detection techniques pave the way for mechanistic understanding. Nat Med. 2015;21:217&#x2013;219. doi: 10.1038/nm.3810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3810</ArticleId><ArticleId IdType="pubmed">25742456</ArticleId></ArticleIdList></Reference><Reference><Citation>Saint-Pol J, Gosselet F, Duban-Deweer S, Pottiez G, Karamanos Y. Targeting and crossing the blood-brain barrier with extracellular vesicles. Cells. 2020;9:851. doi: 10.3390/cells9040851.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040851</ArticleId><ArticleId IdType="pmc">PMC7226770</ArticleId><ArticleId IdType="pubmed">32244730</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, et al. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Transl Neurodegener. 2017;6:8. doi: 10.1186/s40035-017-0076-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-017-0076-6</ArticleId><ArticleId IdType="pmc">PMC5370489</ArticleId><ArticleId IdType="pubmed">28360997</ArticleId></ArticleIdList></Reference><Reference><Citation>Garborg K, Holme &#xd8;, L&#xf8;berg M, Kalager M, Adami HO, Bretthauer M. Current status of screening for colorectal cancer. Ann Oncol. 2013;24:1963&#x2013;1972. doi: 10.1093/annonc/mdt157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdt157</ArticleId><ArticleId IdType="pubmed">23619033</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P, Mesci P, Carromeu C, McClatchy DR, Schiapparelli L, Yates JR, 3rd, et al. Exosomes regulate neurogenesis and circuit assembly. Proc Natl Acad Sci U S A. 2019;116:16086&#x2013;16094. doi: 10.1073/pnas.1902513116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1902513116</ArticleId><ArticleId IdType="pmc">PMC6689941</ArticleId><ArticleId IdType="pubmed">31320591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez SH, Andrews AM, Paul D, Pachter JS. Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers. Fluids Barriers CNS. 2018;15:19. doi: 10.1186/s12987-018-0104-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-018-0104-7</ArticleId><ArticleId IdType="pmc">PMC6026502</ArticleId><ArticleId IdType="pubmed">29960602</ArticleId></ArticleIdList></Reference><Reference><Citation>Howitt J, Hill AF. Exosomes in the pathology of neurodegenerative diseases. J Biol Chem. 2016;291:26589&#x2013;26597. doi: 10.1074/jbc.R116.757955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R116.757955</ArticleId><ArticleId IdType="pmc">PMC5207170</ArticleId><ArticleId IdType="pubmed">27852825</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020 doi: 10.1126/science.aau6977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aau6977</ArticleId><ArticleId IdType="pmc">PMC7717626</ArticleId><ArticleId IdType="pubmed">32029601</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 2014;3:23743. doi: 10.3402/jev.v3.23743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v3.23743</ArticleId><ArticleId IdType="pmc">PMC3968297</ArticleId><ArticleId IdType="pubmed">24683445</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi: 10.1080/20013078.2018.1535750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao H, Im H, Castro CM, Breakefield X, Weissleder R, Lee H. New technologies for analysis of extracellular vesicles. Chem Rev. 2018;118:1917&#x2013;1950. doi: 10.1021/acs.chemrev.7b00534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.7b00534</ArticleId><ArticleId IdType="pmc">PMC6029891</ArticleId><ArticleId IdType="pubmed">29384376</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21:R125&#x2013;134. doi: 10.1093/hmg/dds317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds317</ArticleId><ArticleId IdType="pubmed">22872698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487&#x2013;514. doi: 10.1146/annurev-biochem-013118-111902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biochem-013118-111902</ArticleId><ArticleId IdType="pubmed">31220978</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19:47. doi: 10.1186/s12964-021-00730-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-021-00730-1</ArticleId><ArticleId IdType="pmc">PMC8063428</ArticleId><ArticleId IdType="pubmed">33892745</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 2019;8:307. doi: 10.3390/cells8040307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8040307</ArticleId><ArticleId IdType="pmc">PMC6523673</ArticleId><ArticleId IdType="pubmed">30987213</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G, D'Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213&#x2013;228. doi: 10.1038/nrm.2017.125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.125</ArticleId><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75:193&#x2013;208. doi: 10.1007/s00018-017-2595-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2595-9</ArticleId><ArticleId IdType="pmc">PMC5756260</ArticleId><ArticleId IdType="pubmed">28733901</ArticleId></ArticleIdList></Reference><Reference><Citation>Maas SLN, Breakefield XO, Weaver AM. Extracellular vesicles: unique intercellular delivery vehicles. Trends Cell Biol. 2017;27:172&#x2013;188. doi: 10.1016/j.tcb.2016.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5318253</ArticleId><ArticleId IdType="pubmed">27979573</ArticleId></ArticleIdList></Reference><Reference><Citation>Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neurooncol. 2013;113:1&#x2013;11. doi: 10.1007/s11060-013-1084-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11060-013-1084-8</ArticleId><ArticleId IdType="pmc">PMC5533094</ArticleId><ArticleId IdType="pubmed">23456661</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;zsi A, Kov&#xe1;cs &#xc1;, Visnovitz T, Buz&#xe1;s EI. Systems biology approaches to investigating the roles of extracellular vesicles in human diseases. Exp Mol Med. 2019;51:1&#x2013;11. doi: 10.1038/s12276-019-0226-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0226-2</ArticleId><ArticleId IdType="pmc">PMC6418293</ArticleId><ArticleId IdType="pubmed">30872567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019;21:9&#x2013;17. doi: 10.1038/s41556-018-0250-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-018-0250-9</ArticleId><ArticleId IdType="pubmed">30602770</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang D, Chen J, Hu D, Xie F, Yang T, Li Z, et al. Advances in biological function and clinical application of small extracellular vesicle membrane proteins. Front Oncol. 2021;11:675940. doi: 10.3389/fonc.2021.675940.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.675940</ArticleId><ArticleId IdType="pmc">PMC8172959</ArticleId><ArticleId IdType="pubmed">34094979</ArticleId></ArticleIdList></Reference><Reference><Citation>He C, Zheng S, Luo Y, Wang B. Exosome theranostics: biology and translational medicine. Theranostics. 2018;8:237&#x2013;255. doi: 10.7150/thno.21945.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.21945</ArticleId><ArticleId IdType="pmc">PMC5743472</ArticleId><ArticleId IdType="pubmed">29290805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, et al. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A. 2016;113:E968&#x2013;977. doi: 10.1073/pnas.1521230113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1521230113</ArticleId><ArticleId IdType="pmc">PMC4776515</ArticleId><ArticleId IdType="pubmed">26858453</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz-Siegmund M, Aigner A. Nucleic acid delivery with extracellular vesicles. Adv Drug Deliv Rev. 2021;173:89&#x2013;111. doi: 10.1016/j.addr.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2021.03.005</ArticleId><ArticleId IdType="pubmed">33746014</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24:766&#x2013;769. doi: 10.1038/cr.2014.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2014.44</ArticleId><ArticleId IdType="pmc">PMC4042169</ArticleId><ArticleId IdType="pubmed">24710597</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone P, Savini C, Kurelac I, Chang Q, Amato LB, Strillacci A, et al. Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci U S A. 2017;114:E9066&#x2013;e9075. doi: 10.1073/pnas.1704862114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704862114</ArticleId><ArticleId IdType="pmc">PMC5664494</ArticleId><ArticleId IdType="pubmed">29073103</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y, et al. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res. 2018;46:D106&#x2013;D112. doi: 10.1093/nar/gkx891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx891</ArticleId><ArticleId IdType="pmc">PMC5753357</ArticleId><ArticleId IdType="pubmed">30053265</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombo M, Raposo G, Th&#xe9;ry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255&#x2013;289. doi: 10.1146/annurev-cellbio-101512-122326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-101512-122326</ArticleId><ArticleId IdType="pubmed">25288114</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien K, Breyne K, Ughetto S, Laurent LC, Breakefield XO. RNA delivery by extracellular vesicles in mammalian cells and its applications. Nat Rev Mol Cell Biol. 2020;21:585&#x2013;606. doi: 10.1038/s41580-020-0251-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0251-y</ArticleId><ArticleId IdType="pmc">PMC7249041</ArticleId><ArticleId IdType="pubmed">32457507</ArticleId></ArticleIdList></Reference><Reference><Citation>de Voogt WS, Tanenbaum ME, Vader P. Illuminating RNA trafficking and functional delivery by extracellular vesicles. Adv Drug Deliv Rev. 2021;174:250&#x2013;264. doi: 10.1016/j.addr.2021.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2021.04.017</ArticleId><ArticleId IdType="pubmed">33894328</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16:421&#x2013;433. doi: 10.1038/nrg3965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3965</ArticleId><ArticleId IdType="pubmed">26077373</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmiedel JM, Klemm SL, Zheng Y, Sahay A, Bl&#xfc;thgen N, Marks DS, et al. Gene expression. MicroRNA control of protein expression noise. Science. 2015;348:128&#x2013;132. doi: 10.1126/science.aaa1738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa1738</ArticleId><ArticleId IdType="pubmed">25838385</ArticleId></ArticleIdList></Reference><Reference><Citation>Walgrave H, Zhou L, De Strooper B, Salta E. The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives. Mol Neurodegener. 2021;16:76. doi: 10.1186/s13024-021-00496-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00496-7</ArticleId><ArticleId IdType="pmc">PMC8572071</ArticleId><ArticleId IdType="pubmed">34742333</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez B, Peplow PV. MicroRNAs as diagnostic and therapeutic tools for Alzheimer's disease: advances and limitations. Neural Regen Res. 2019;14:242&#x2013;255. doi: 10.4103/1673-5374.244784.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.244784</ArticleId><ArticleId IdType="pmc">PMC6301178</ArticleId><ArticleId IdType="pubmed">30531004</ArticleId></ArticleIdList></Reference><Reference><Citation>Skotland T, Sandvig K, Llorente A. Lipids in exosomes: current knowledge and the way forward. Prog Lipid Res. 2017;66:30&#x2013;41. doi: 10.1016/j.plipres.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2017.03.001</ArticleId><ArticleId IdType="pubmed">28342835</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreimer S, Belov AM, Ghiran I, Murthy SK, Frank DA, Ivanov AR. Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics. J Proteome Res. 2015;14:2367&#x2013;2384. doi: 10.1021/pr501279t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr501279t</ArticleId><ArticleId IdType="pubmed">25927954</ArticleId></ArticleIdList></Reference><Reference><Citation>Skotland T, Hessvik NP, Sandvig K, Llorente A. Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology. J Lipid Res. 2019;60:9&#x2013;18. doi: 10.1194/jlr.R084343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.R084343</ArticleId><ArticleId IdType="pmc">PMC6314266</ArticleId><ArticleId IdType="pubmed">30076207</ArticleId></ArticleIdList></Reference><Reference><Citation>Beloribi S, Ristorcelli E, Breuzard G, Silvy F, Bertrand-Michel J, Beraud E, et al. Exosomal lipids impact notch signaling and induce death of human pancreatic tumoral SOJ-6 cells. PLoS ONE. 2012;7:e47480. doi: 10.1371/journal.pone.0047480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0047480</ArticleId><ArticleId IdType="pmc">PMC3477155</ArticleId><ArticleId IdType="pubmed">23094054</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao L, Zhou J, Yuan C, Zhang L, Li D, Si D, et al. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Metabolomics. 2019;15:86. doi: 10.1007/s11306-019-1550-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-019-1550-1</ArticleId><ArticleId IdType="pubmed">31147790</ArticleId></ArticleIdList></Reference><Reference><Citation>Record M, Silvente-Poirot S, Poirot M, Wakelam MJO. Extracellular vesicles: lipids as key components of their biogenesis and functions. J Lipid Res. 2018;59:1316&#x2013;1324. doi: 10.1194/jlr.E086173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.E086173</ArticleId><ArticleId IdType="pmc">PMC6071772</ArticleId><ArticleId IdType="pubmed">29764923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung S, Dutta S, Bitan G. CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges. Front Mol Neurosci. 2020;13:38. doi: 10.3389/fnmol.2020.00038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00038</ArticleId><ArticleId IdType="pmc">PMC7096580</ArticleId><ArticleId IdType="pubmed">32265650</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Zong S, Wang Z, Lu J, Zhu D, Zhang Y, et al. Visualization and intracellular dynamic tracking of exosomes and exosomal miRNAs using single molecule localization microscopy. Nanoscale. 2018;10:5154&#x2013;5162. doi: 10.1039/C7NR08800K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7NR08800K</ArticleId><ArticleId IdType="pubmed">29492481</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G, Carter DRF, Clayton A, Lambert DW, Raposo G, Vader P. Challenges and directions in studying cell-cell communication by extracellular vesicles. Nat Rev Mol Cell Biol. 2022;23:369&#x2013;382. doi: 10.1038/s41580-022-00460-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-022-00460-3</ArticleId><ArticleId IdType="pubmed">35260831</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CP, Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol. 2012;3:228. doi: 10.3389/fphys.2012.00228.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00228</ArticleId><ArticleId IdType="pmc">PMC3384085</ArticleId><ArticleId IdType="pubmed">22754538</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpe C, Monaco L, Relucenti M, Iovino L, Familiari P, Scavizzi F, et al. Microglia-derived small extracellular vesicles reduce glioma growth by modifying tumor cell metabolism and enhancing glutamate clearance through miR-124. Cells. 2021;10:2066. doi: 10.3390/cells10082066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082066</ArticleId><ArticleId IdType="pmc">PMC8393731</ArticleId><ArticleId IdType="pubmed">34440835</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor AR, Robinson MB, Gifondorwa DJ, Tytell M, Milligan CE. Regulation of heat shock protein 70 release in astrocytes: role of signaling kinases. Dev Neurobiol. 2007;67:1815&#x2013;1829. doi: 10.1002/dneu.20559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dneu.20559</ArticleId><ArticleId IdType="pubmed">17701989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Cesca F, Loers G, Schweizer M, Buck F, Benfenati F, et al. Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. J Neurosci. 2011;31:7275&#x2013;7290. doi: 10.1523/JNEUROSCI.6476-10.2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.6476-10.2011</ArticleId><ArticleId IdType="pmc">PMC6622588</ArticleId><ArticleId IdType="pubmed">21593312</ArticleId></ArticleIdList></Reference><Reference><Citation>Glebov K, L&#xf6;chner M, Jabs R, Lau T, Merkel O, Schloss P, et al. Serotonin stimulates secretion of exosomes from microglia cells. Glia. 2015;63:626&#x2013;634. doi: 10.1002/glia.22772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22772</ArticleId><ArticleId IdType="pubmed">25451814</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S, Borlongan CV. Stem cell-derived extracellular vesicles as potential mechanism for repair of microvascular damage within and outside of the central nervous system in amyotrophic lateral sclerosis: perspective schema. Neural Regen Res. 2021;16:680&#x2013;681. doi: 10.4103/1673-5374.294337.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.294337</ArticleId><ArticleId IdType="pmc">PMC8067951</ArticleId><ArticleId IdType="pubmed">33063723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardar Sinha M, Ansell-Schultz A, Civitelli L, Hildesjo C, Larsson M, Lannfelt L, et al. Alzheimer's disease pathology propagation by exosomes containing toxic amyloid-beta oligomers. Acta Neuropathol. 2018;136:41&#x2013;56. doi: 10.1007/s00401-018-1868-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1868-1</ArticleId><ArticleId IdType="pmc">PMC6015111</ArticleId><ArticleId IdType="pubmed">29934873</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M, Wang J, Zhao Y, Feng Y, Han S, Dong Q, et al. Microglial exosomes facilitate alpha-synuclein transmission in Parkinson's disease. Brain. 2020;143:1476&#x2013;1497. doi: 10.1093/brain/awaa090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa090</ArticleId><ArticleId IdType="pmc">PMC7241957</ArticleId><ArticleId IdType="pubmed">32355963</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Romero N, Carri&#xf3;n-Navarro J, Esteban-Rubio S, L&#xe1;zaro-Ib&#xe1;&#xf1;ez E, Peris-Celda M, Alonso MM, et al. DNA sequences within glioma-derived extracellular vesicles can cross the intact blood-brain barrier and be detected in peripheral blood of patients. Oncotarget. 2017;8:1416&#x2013;1428. doi: 10.18632/oncotarget.13635.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13635</ArticleId><ArticleId IdType="pmc">PMC5352065</ArticleId><ArticleId IdType="pubmed">27902458</ArticleId></ArticleIdList></Reference><Reference><Citation>Jingushi K, Uemura M, Ohnishi N, Nakata W, Fujita K, Naito T, et al. Extracellular vesicles isolated from human renal cell carcinoma tissues disrupt vascular endothelial cell morphology via azurocidin. Int J Cancer. 2018;142:607&#x2013;617. doi: 10.1002/ijc.31080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.31080</ArticleId><ArticleId IdType="pubmed">28975613</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzheimer's disease facts and figures Alzheimers Dement. 2022;18:700&#x2013;789. doi: 10.1002/alz.12638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12638</ArticleId><ArticleId IdType="pubmed">35289055</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 2011;1:a006189. doi: 10.1101/cshperspect.a006189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006189</ArticleId><ArticleId IdType="pmc">PMC3234452</ArticleId><ArticleId IdType="pubmed">22229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Selkoe DJ. Neurotoxicity of amyloid &#x3b2;-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012;2:a006338. doi: 10.1101/cshperspect.a006338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006338</ArticleId><ArticleId IdType="pmc">PMC3385944</ArticleId><ArticleId IdType="pubmed">22762015</ArticleId></ArticleIdList></Reference><Reference><Citation>Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012;2:a006270. doi: 10.1101/cshperspect.a006270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a006270</ArticleId><ArticleId IdType="pmc">PMC3331683</ArticleId><ArticleId IdType="pubmed">22553493</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JH, Ostalecki C, Oberstein T, Schierer S, Zinser E, Eberhardt M, et al. Alzheimer's disease protease-containing plasma extracellular vesicles transfer to the hippocampus via the choroid plexus. EBioMedicine. 2022;77:103903. doi: 10.1016/j.ebiom.2022.103903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103903</ArticleId><ArticleId IdType="pmc">PMC8889140</ArticleId><ArticleId IdType="pubmed">35220044</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent B. Plasma extracellular vesicles from the periphery as spreading vectors of Alzheimer's disease pathogenesis? EBioMedicine. 2022;78:103961. doi: 10.1016/j.ebiom.2022.103961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103961</ArticleId><ArticleId IdType="pmc">PMC8938881</ArticleId><ArticleId IdType="pubmed">35325782</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrielli M, Prada I, Joshi P, Falcicchia C, D'Arrigo G, Rutigliano G, et al. Microglial large extracellular vesicles propagate early synaptic dysfunction in Alzheimer's disease. Brain. 2022;145:2849&#x2013;2868. doi: 10.1093/brain/awac083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac083</ArticleId><ArticleId IdType="pmc">PMC9420022</ArticleId><ArticleId IdType="pubmed">35254410</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11(600&#x2013;607):e601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4329112</ArticleId><ArticleId IdType="pubmed">25130657</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkins MB, Enasko J, Hernandez C, Wang G, Kong J, Helwa I, et al. Neutral sphingomyelinase-2 deficiency ameliorates Alzheimer's disease pathology and improves cognition in the 5XFAD mouse. J Neurosci. 2016;36:8653&#x2013;8667. doi: 10.1523/JNEUROSCI.1429-16.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1429-16.2016</ArticleId><ArticleId IdType="pmc">PMC4987436</ArticleId><ArticleId IdType="pubmed">27535912</ArticleId></ArticleIdList></Reference><Reference><Citation>Villemagne VL, Dor&#xe9; V, Burnham SC, Masters CL, Rowe CC. Imaging tau and amyloid-&#x3b2; proteinopathies in Alzheimer disease and other conditions. Nat Rev Neurol. 2018;14:225&#x2013;236. doi: 10.1038/nrneurol.2018.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2018.9</ArticleId><ArticleId IdType="pubmed">29449700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2014;35:1792&#x2013;1800. doi: 10.1016/j.neurobiolaging.2014.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.012</ArticleId><ArticleId IdType="pmc">PMC4035236</ArticleId><ArticleId IdType="pubmed">24650793</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Dalla Libera D, Spinelli EG, Finardi A, Canu E, Bergami A, et al. Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease. Ann Neurol. 2014;76:813&#x2013;825. doi: 10.1002/ana.24235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24235</ArticleId><ArticleId IdType="pubmed">25087695</ArticleId></ArticleIdList></Reference><Reference><Citation>Podvin S, Jones A, Liu Q, Aulston B, Mosier C, Ames J, et al. Mutant presenilin 1 dysregulates exosomal proteome cargo produced by human-induced pluripotent stem cell neurons. ACS Omega. 2021;6:13033&#x2013;13056. doi: 10.1021/acsomega.1c00660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.1c00660</ArticleId><ArticleId IdType="pmc">PMC8158845</ArticleId><ArticleId IdType="pubmed">34056454</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L, Qiu Q, Zhang H, Chu L, Du Y, Zhang J, et al. Concordance between the assessment of A&#x3b2;42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15:1071&#x2013;1080. doi: 10.1016/j.jalz.2019.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2019.05.002</ArticleId><ArticleId IdType="pubmed">31422798</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallart-Palau X, Guo X, Serra A, Sze SK. Alzheimer's disease progression characterized by alterations in the molecular profiles and biogenesis of brain extracellular vesicles. Alzheimers Res Ther. 2020;12:54. doi: 10.1186/s13195-020-00623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00623-4</ArticleId><ArticleId IdType="pmc">PMC7210691</ArticleId><ArticleId IdType="pubmed">32384937</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraoka S, DeLeo AM, Sethi MK, Yukawa-Takamatsu K, Yang Z, Ko J, et al. Proteomic and biological profiling of extracellular vesicles from Alzheimer's disease human brain tissues. Alzheimers Dement. 2020;16:896&#x2013;907. doi: 10.1002/alz.12089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12089</ArticleId><ArticleId IdType="pmc">PMC7293582</ArticleId><ArticleId IdType="pubmed">32301581</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco JC, Scicluna BJ, Hill AF, G&#xf6;tz J. Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner. J Biol Chem. 2016;291:12445&#x2013;12466. doi: 10.1074/jbc.M115.709485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.709485</ArticleId><ArticleId IdType="pmc">PMC4933440</ArticleId><ArticleId IdType="pubmed">27030011</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeever PM, Schneider R, Taghdiri F, Weichert A, Multani N, Brown RA, et al. MicroRNA expression levels are altered in the cerebrospinal fluid of patients with young-onset Alzheimer's disease. Mol Neurobiol. 2018;55:8826&#x2013;8841. doi: 10.1007/s12035-018-1032-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1032-x</ArticleId><ArticleId IdType="pmc">PMC6208843</ArticleId><ArticleId IdType="pubmed">29603092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CG, Meng S, Li Y, Lu Y, Zhao Y, Wang PC. MicroRNA-135a in ABCA1-labeled exosome is a serum biomarker candidate for Alzheimer's disease. Biomed Environ Sci. 2021;34:19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">33531104</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Meng S, Di W, Xia M, Dong L, Zhao Y, et al. Amyloid-&#x3b2; protein and MicroRNA-384 in NCAM-Labeled exosomes from peripheral blood are potential diagnostic markers for Alzheimer's disease. CNS Neurosci Ther. 2022;28:1093&#x2013;1107. doi: 10.1111/cns.13846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13846</ArticleId><ArticleId IdType="pmc">PMC9160455</ArticleId><ArticleId IdType="pubmed">35470961</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Xia M, Meng S, Wu D, Ling S, Chen X, et al. MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline. Neurobiol Dis. 2022;171:105800. doi: 10.1016/j.nbd.2022.105800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2022.105800</ArticleId><ArticleId IdType="pubmed">35752392</ArticleId></ArticleIdList></Reference><Reference><Citation>Aharon A, Spector P, Ahmad RS, Horrany N, Sabbach A, Brenner B, et al. Extracellular vesicles of Alzheimer's disease patients as a biomarker for disease progression. Mol Neurobiol. 2020;57:4156&#x2013;4169. doi: 10.1007/s12035-020-02013-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02013-1</ArticleId><ArticleId IdType="pubmed">32676990</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CG, Zhao Y, Lu Y, Wang PC. ABCA1-labeled exosomes in serum contain higher microRNA-193b levels in Alzheimer's disease. Biomed Res Int. 2021;2021:5450397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7963893</ArticleId><ArticleId IdType="pubmed">33763470</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC. The serum exosome derived microRNA-135a, -193b, and -384 were potential Alzheimer's disease biomarkers. Biomed Environ Sci. 2018;31:87&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">29606187</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, Lee JU, Jeon MJ, Kim S, Sim SJ. Detection of multiplex exosomal miRNAs for clinically accurate diagnosis of Alzheimer's disease using label-free plasmonic biosensor based on DNA-Assembled advanced plasmonic architecture. Biosens Bioelectron. 2022;199:113864. doi: 10.1016/j.bios.2021.113864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2021.113864</ArticleId><ArticleId IdType="pubmed">34890883</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Z, Gu H, Guo Q, Liang S, Xue J, Yao F, et al. Profiling of serum exosome miRNA reveals the potential of a miRNA panel as diagnostic biomarker for Alzheimer's disease. Mol Neurobiol. 2021;58:3084&#x2013;3094. doi: 10.1007/s12035-021-02323-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02323-y</ArticleId><ArticleId IdType="pubmed">33629272</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpente M, Fenoglio C, D'Anca M, Arcaro M, Sorrentino F, Visconte C, et al. MiRNA profiling in plasma neural-derived small extracellular vesicles from patients with Alzheimer's disease. Cells. 2020;9:1443. doi: 10.3390/cells9061443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9061443</ArticleId><ArticleId IdType="pmc">PMC7349735</ArticleId><ArticleId IdType="pubmed">32531989</ArticleId></ArticleIdList></Reference><Reference><Citation>Durur DY, Tastan B, Ugur Tufekci K, Olcum M, Uzuner H, Karak&#xfc;lah G, et al. Alteration of miRNAs in small neuron-derived extracellular vesicles of alzheimer's disease patients and the effect of extracellular vesicles on microglial immune responses. J Mol Neurosci. 2022;72:1182&#x2013;1194. doi: 10.1007/s12031-022-02012-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-022-02012-y</ArticleId><ArticleId IdType="pubmed">35488079</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano M, Kubota K, Kobayashi E, Chikenji TS, Saito Y, Konari N, et al. Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer's disease model by increasing the expression of microRNA-146a in hippocampus. Sci Rep. 2020;10:10772. doi: 10.1038/s41598-020-67460-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-67460-1</ArticleId><ArticleId IdType="pmc">PMC7330036</ArticleId><ArticleId IdType="pubmed">32612165</ArticleId></ArticleIdList></Reference><Reference><Citation>Younas N, Fernandez Flores LC, Hopfner F, H&#xf6;glinger GU, Zerr I. A new paradigm for diagnosis of neurodegenerative diseases: peripheral exosomes of brain origin. Transl Neurodegener. 2022;11:28. doi: 10.1186/s40035-022-00301-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00301-5</ArticleId><ArticleId IdType="pmc">PMC9082915</ArticleId><ArticleId IdType="pubmed">35527262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006;103:11172&#x2013;11177. doi: 10.1073/pnas.0603838103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0603838103</ArticleId><ArticleId IdType="pmc">PMC1544060</ArticleId><ArticleId IdType="pubmed">16837572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouwens LK, Ismail MS, Rogers VA, Zeller NT, Garrad EC, Amtashar FS, et al. A&#x3b2;42 Protofibrils interact with and are trafficked through microglial-derived microvesicles. ACS Chem Neurosci. 2018;9:1416&#x2013;1425. doi: 10.1021/acschemneuro.8b00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00029</ArticleId><ArticleId IdType="pubmed">29543435</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi P, Turola E, Ruiz A, Bergami A, Libera DD, Benussi L, et al. Microglia convert aggregated amyloid-&#x3b2; into neurotoxic forms through the shedding of microvesicles. Cell Death Differ. 2014;21:582&#x2013;593. doi: 10.1038/cdd.2013.180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2013.180</ArticleId><ArticleId IdType="pmc">PMC3950321</ArticleId><ArticleId IdType="pubmed">24336048</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsherbini A, Qin H, Zhu Z, Tripathi P, Crivelli SM, Bieberich E. In vivo evidence of exosome-mediated A&#x3b2; neurotoxicity. Acta Neuropathol Commun. 2020;8:100. doi: 10.1186/s40478-020-00981-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-00981-y</ArticleId><ArticleId IdType="pmc">PMC7339450</ArticleId><ArticleId IdType="pubmed">32631455</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Balaji V, Kaniyappan S, Kr&#xfc;ger L, Irsen S, Tepper K, et al. The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener. 2017;12:5. doi: 10.1186/s13024-016-0143-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0143-y</ArticleId><ArticleId IdType="pmc">PMC5237256</ArticleId><ArticleId IdType="pubmed">28086931</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T, et al. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model. Mol Neurodegener. 2021;16:18. doi: 10.1186/s13024-021-00440-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00440-9</ArticleId><ArticleId IdType="pmc">PMC7986521</ArticleId><ArticleId IdType="pubmed">33752701</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015;18:1584&#x2013;1593. doi: 10.1038/nn.4132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4132</ArticleId><ArticleId IdType="pmc">PMC4694577</ArticleId><ArticleId IdType="pubmed">26436904</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacheco-Quinto J, Clausen D, P&#xe9;rez-Gonz&#xe1;lez R, Peng H, Meszaros A, Eckman CB, et al. Intracellular metalloprotease activity controls intraneuronal A&#x3b2; aggregation and limits secretion of A&#x3b2; via exosomes. FASEB J. 2019;33:3758&#x2013;3771. doi: 10.1096/fj.201801319R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801319R</ArticleId><ArticleId IdType="pmc">PMC6404562</ArticleId><ArticleId IdType="pubmed">30481490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S, et al. Alteration of the microRNA network during the progression of Alzheimer's disease. EMBO Mol Med. 2013;5:1613&#x2013;1634. doi: 10.1002/emmm.201201974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201974</ArticleId><ArticleId IdType="pmc">PMC3799583</ArticleId><ArticleId IdType="pubmed">24014289</ArticleId></ArticleIdList></Reference><Reference><Citation>Canseco-Rodriguez A, Masola V, Aliperti V, Meseguer-Beltran M, Donizetti A, Sanchez-Perez AM. Long non-coding RNAs, extracellular vesicles and inflammation in Alzheimer's disease. Int J Mol Sci. 2022;23:13171. doi: 10.3390/ijms232113171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232113171</ArticleId><ArticleId IdType="pmc">PMC9654199</ArticleId><ArticleId IdType="pubmed">36361952</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitz NF, Wang J, Kamboh MI, Koldamova R, Lefterov I. Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's disease. Neurobiol Dis. 2021;159:105481. doi: 10.1016/j.nbd.2021.105481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105481</ArticleId><ArticleId IdType="pmc">PMC9382696</ArticleId><ArticleId IdType="pubmed">34411703</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman M, Ter-Ovanesyan D, Trieu W, Lazarovits R, Kowal EJK, Lee JH, et al. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat Methods. 2021;18:631&#x2013;634. doi: 10.1038/s41592-021-01174-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01174-8</ArticleId><ArticleId IdType="pmc">PMC9075416</ArticleId><ArticleId IdType="pubmed">34092791</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurado-Coronel JC, Cabezas R, &#xc1;vila Rodr&#xed;guez MF, Echeverria V, Garc&#xed;a-Segura LM, Barreto GE. Sex differences in Parkinson's disease: features on clinical symptoms, treatment outcome, sexual hormones and genetics. Front Neuroendocrinol. 2018;50:18&#x2013;30. doi: 10.1016/j.yfrne.2017.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2017.09.002</ArticleId><ArticleId IdType="pubmed">28974386</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PK, Muqit MMK. Parkinson's: a disease of aberrant vesicle trafficking. Annu Rev Cell Dev Biol. 2020;36:237&#x2013;264. doi: 10.1146/annurev-cellbio-100818-125512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100818-125512</ArticleId><ArticleId IdType="pubmed">32749865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassama Y, Favereaux A. Emerging roles of extracellular vesicles in the central nervous system: physiology, pathology, and therapeutic perspectives. Front Cell Neurosci. 2021;15:626043. doi: 10.3389/fncel.2021.626043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.626043</ArticleId><ArticleId IdType="pmc">PMC7940515</ArticleId><ArticleId IdType="pubmed">33708073</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci. 2005;25:6016&#x2013;6024. doi: 10.1523/JNEUROSCI.0692-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0692-05.2005</ArticleId><ArticleId IdType="pmc">PMC6724798</ArticleId><ArticleId IdType="pubmed">15976091</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L, Seow Y, Schapira AH, Gardiner C, Sargent IL, Wood MJ, et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis. 2011;42:360&#x2013;367. doi: 10.1016/j.nbd.2011.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.029</ArticleId><ArticleId IdType="pmc">PMC3107939</ArticleId><ArticleId IdType="pubmed">21303699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa T, Konno M, Baba T, Sugeno N, Kikuchi A, Kobayashi M, et al. The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of &#x3b1;-synuclein. PLoS ONE. 2011;6:e29460. doi: 10.1371/journal.pone.0029460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029460</ArticleId><ArticleId IdType="pmc">PMC3245276</ArticleId><ArticleId IdType="pubmed">22216284</ArticleId></ArticleIdList></Reference><Reference><Citation>Grey M, Dunning CJ, Gaspar R, Grey C, Brundin P, Sparr E, et al. Acceleration of &#x3b1;-synuclein aggregation by exosomes. J Biol Chem. 2015;290:2969&#x2013;2982. doi: 10.1074/jbc.M114.585703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.585703</ArticleId><ArticleId IdType="pmc">PMC4317028</ArticleId><ArticleId IdType="pubmed">25425650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan RZ, Guo M, Luo S, Cui M, Tieu K. Exosome release and neuropathology induced by &#x3b1;-synuclein: new insights into protective mechanisms of Drp1 inhibition. Acta Neuropathol Commun. 2019;7:184. doi: 10.1186/s40478-019-0821-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0821-4</ArticleId><ArticleId IdType="pmc">PMC6862865</ArticleId><ArticleId IdType="pubmed">31744532</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliederhaeuser C, Grozdanov V, Speidel A, Zondler L, Ruf WP, Bayer H, et al. Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes. Acta Neuropathol. 2016;131:379&#x2013;391. doi: 10.1007/s00401-015-1504-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1504-2</ArticleId><ArticleId IdType="pubmed">26576561</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuendl A, Kraus T, Chatterjee M, Zapke B, Sadowski B, Moebius W, et al. &#x3b1;-Synuclein in plasma-derived extracellular vesicles is a potential biomarker of Parkinson's disease. Mov Disord. 2021;36:2508&#x2013;2518. doi: 10.1002/mds.28639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28639</ArticleId><ArticleId IdType="pubmed">34002893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohmichi T, Mitsuhashi M, Tatebe H, Kasai T, Ali El-Agnaf OM, Tokuda T. Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson's and related diseases. Parkinsonism Relat Disord. 2019;61:82&#x2013;87. doi: 10.1016/j.parkreldis.2018.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2018.11.021</ArticleId><ArticleId IdType="pubmed">30502924</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos MCT, Barreto-Sanz MA, Correia BRS, Bell R, Widnall C, Perez LT, et al. miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson's disease. Oncotarget. 2018;9:17455&#x2013;17465. doi: 10.18632/oncotarget.24736.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.24736</ArticleId><ArticleId IdType="pmc">PMC5915128</ArticleId><ArticleId IdType="pubmed">29707120</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui Y, Liu H, Zhang L, Lv W, Hu X. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease. Oncotarget. 2015;6:37043&#x2013;37053. doi: 10.18632/oncotarget.6158.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6158</ArticleId><ArticleId IdType="pmc">PMC4741914</ArticleId><ArticleId IdType="pubmed">26497684</ArticleId></ArticleIdList></Reference><Reference><Citation>Manna I, Quattrone A, De Benedittis S, Vescio B, Iaccino E, Quattrone A. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study. Parkinsonism Relat Disord. 2021;93:77&#x2013;84. doi: 10.1016/j.parkreldis.2021.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2021.11.020</ArticleId><ArticleId IdType="pubmed">34839044</ArticleId></ArticleIdList></Reference><Reference><Citation>He S, Huang L, Shao C, Nie T, Xia L, Cui B, et al. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease. Transl Neurodegener. 2021;10:25. doi: 10.1186/s40035-021-00249-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-021-00249-y</ArticleId><ArticleId IdType="pmc">PMC8317324</ArticleId><ArticleId IdType="pubmed">34315539</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbagallo C, Mostile G, Baglieri G, Giunta F, Luca A, Raciti L, et al. Specific signatures of serum miRNAs as potential biomarkers to discriminate clinically similar neurodegenerative and vascular-related diseases. Cell Mol Neurobiol. 2020;40:531&#x2013;546. doi: 10.1007/s10571-019-00751-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-019-00751-y</ArticleId><ArticleId IdType="pubmed">31691877</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao XY, Lu JM, Zhao ZQ, Li MC, Lu T, An XS, et al. MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles. Neurosci Lett. 2017;644:94&#x2013;99. doi: 10.1016/j.neulet.2017.02.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.02.045</ArticleId><ArticleId IdType="pubmed">28223160</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdilek B, Demircan B. Serum microRNA expression levels in Turkish patients with Parkinson's disease. Int J Neurosci. 2021;131:1181&#x2013;1189. doi: 10.1080/00207454.2020.1784165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2020.1784165</ArticleId><ArticleId IdType="pubmed">32546033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao YF, Qu MW, Li GC, Zhang FB, Rui HC. Circulating exosomal miRNAs as diagnostic biomarkers in Parkinson's disease. Eur Rev Med Pharmacol Sci. 2018;22:5278&#x2013;5283.</Citation><ArticleIdList><ArticleId IdType="pubmed">30178852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie C, Sun Y, Zhen H, Guo M, Ye J, Liu Z, et al. Differential expression of plasma exo-miRNA in neurodegenerative diseases by next-generation sequencing. Front Neurosci. 2020;14:438. doi: 10.3389/fnins.2020.00438.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00438</ArticleId><ArticleId IdType="pmc">PMC7227778</ArticleId><ArticleId IdType="pubmed">32457573</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie S, Niu W, Xu F, Wang Y, Hu S, Niu C. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease. Int J Neurosci. 2022;132:673&#x2013;688. doi: 10.1080/00207454.2020.1835899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00207454.2020.1835899</ArticleId><ArticleId IdType="pubmed">33045885</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30:6838&#x2013;6851. doi: 10.1523/JNEUROSCI.5699-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5699-09.2010</ArticleId><ArticleId IdType="pmc">PMC3842464</ArticleId><ArticleId IdType="pubmed">20484626</ArticleId></ArticleIdList></Reference><Reference><Citation>Satake W, Nakabayashi Y, Mizuta I, Hirota Y, Ito C, Kubo M, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet. 2009;41:1303&#x2013;1307. doi: 10.1038/ng.485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.485</ArticleId><ArticleId IdType="pubmed">19915576</ArticleId></ArticleIdList></Reference><Reference><Citation>Shults CW. Lewy bodies. Proc Natl Acad Sci U S A. 2006;103:1661&#x2013;1668. doi: 10.1073/pnas.0509567103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509567103</ArticleId><ArticleId IdType="pmc">PMC1413649</ArticleId><ArticleId IdType="pubmed">16449387</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques O, Outeiro TF. Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis. 2012;3:e350. doi: 10.1038/cddis.2012.94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2012.94</ArticleId><ArticleId IdType="pmc">PMC3406593</ArticleId><ArticleId IdType="pubmed">22825468</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, et al. Plasma exosomal &#x3b1;-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 2014;128:639&#x2013;650. doi: 10.1007/s00401-014-1314-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1314-y</ArticleId><ArticleId IdType="pmc">PMC4201967</ArticleId><ArticleId IdType="pubmed">24997849</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang C, Hopfner F, Katsikoudi A, Hein R, Catli C, Evetts S, et al. Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism. J Neurol Neurosurg Psychiatry. 2020;91:720&#x2013;729. doi: 10.1136/jnnp-2019-322588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-322588</ArticleId><ArticleId IdType="pmc">PMC7361010</ArticleId><ArticleId IdType="pubmed">32273329</ArticleId></ArticleIdList></Reference><Reference><Citation>Roser AE, Caldi Gomes L, Sch&#xfc;nemann J, Maass F, Lingor P. Circulating miRNAs as diagnostic biomarkers for Parkinson's disease. Front Neurosci. 2018;12:625. doi: 10.3389/fnins.2018.00625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00625</ArticleId><ArticleId IdType="pmc">PMC6135037</ArticleId><ArticleId IdType="pubmed">30233304</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Zheng D, Nao J. Circulating exosome microRNAs as diagnostic biomarkers of dementia. Front Aging Neurosci. 2020;12:580199. doi: 10.3389/fnagi.2020.580199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.580199</ArticleId><ArticleId IdType="pmc">PMC7506134</ArticleId><ArticleId IdType="pubmed">33093831</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O, Bordoni M, Diamanti L, Sproviero D, Gagliardi S, Cereda C. SOD1 in amyotrophic lateral sclerosis: "ambivalent" behavior connected to the disease. Int J Mol Sci. 2018;19:1345. doi: 10.3390/ijms19051345.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19051345</ArticleId><ArticleId IdType="pmc">PMC5983710</ArticleId><ArticleId IdType="pubmed">29751510</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E, Steinacker P, Lehnert S, Schneider A, Walther P, Thal DR, et al. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:351&#x2013;356. doi: 10.3109/21678421.2014.905606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.905606</ArticleId><ArticleId IdType="pubmed">24834468</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki Y, Manzano R, Lee Y, Dafinca R, Aoki M, Douglas AGL, et al. C9orf72 and RAB7L1 regulate vesicle trafficking in amyotrophic lateral sclerosis and frontotemporal dementia. Brain. 2017;140:887&#x2013;897. doi: 10.1093/brain/awx024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx024</ArticleId><ArticleId IdType="pubmed">28334866</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T, Jensen BK, Wen X, Cai J, Kropf E, Iacovitti L, et al. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016;17:645&#x2013;652. doi: 10.1016/j.celrep.2016.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.09.032</ArticleId><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Keller S, Altevogt P, Costa J. Evidence for secretion of Cu, Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett. 2007;428:43&#x2013;46. doi: 10.1016/j.neulet.2007.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2007.09.024</ArticleId><ArticleId IdType="pubmed">17942226</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso M, Pozzi S, Tortarolo M, Fiordaliso F, Bisighini C, Pasetto L, et al. Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease spreading and motor neuron pathology in amyotrophic lateral sclerosis. J Biol Chem. 2013;288:15699&#x2013;15711. doi: 10.1074/jbc.M112.425066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.425066</ArticleId><ArticleId IdType="pmc">PMC3668729</ArticleId><ArticleId IdType="pubmed">23592792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, La Salvia S, Giannini M, Crippa V, Gagliardi S, Bernuzzi S, et al. Pathological proteins are transported by extracellular vesicles of sporadic amyotrophic lateral sclerosis patients. Front Neurosci. 2018;12:487. doi: 10.3389/fnins.2018.00487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00487</ArticleId><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T, et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ, et al. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun. 2018;9:4220. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, et al. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol. 2015;211:897&#x2013;911. doi: 10.1083/jcb.201504057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201504057</ArticleId><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamelgarn M, Chen J, Kuang L, Arenas A, Zhai J, Zhu H, et al. Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS. Biochim Biophys Acta. 2016;1862:2004&#x2013;2014. doi: 10.1016/j.bbadis.2016.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.07.015</ArticleId><ArticleId IdType="pmc">PMC5055831</ArticleId><ArticleId IdType="pubmed">27460707</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzuti M, Melzi V, Gagliardi D, Resnati D, Meneri M, Dioni L, et al. Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes. Cell Mol Life Sci. 2022;79:189. doi: 10.1007/s00018-022-04217-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04217-1</ArticleId><ArticleId IdType="pmc">PMC8921154</ArticleId><ArticleId IdType="pubmed">35286466</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelick J, Men Y, Jin S, Seo S, Espejo-Porras F, Yang Y. Elevated exosomal secretion of miR-124-3p from spinal neurons positively associates with disease severity in ALS. Exp Neurol. 2020;333:113414. doi: 10.1016/j.expneurol.2020.113414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113414</ArticleId><ArticleId IdType="pmc">PMC7502520</ArticleId><ArticleId IdType="pubmed">32712030</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, M&#xfc;ller K, Ludolph AC, Weishaupt JH. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis. Acta Neuropathol Commun. 2013;1:42. doi: 10.1186/2051-5960-1-42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-1-42</ArticleId><ArticleId IdType="pmc">PMC3893596</ArticleId><ArticleId IdType="pubmed">24252274</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Zhao Y, Zhou X, Luan J, Cui Y, Han J. Comparison of the extraction and determination of serum exosome and miRNA in serum and the detection of miR-27a-3p in serum exosome of ALS patients. Intractable Rare Dis Res. 2018;7:13&#x2013;18. doi: 10.5582/irdr.2017.01091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/irdr.2017.01091</ArticleId><ArticleId IdType="pmc">PMC5849619</ArticleId><ArticleId IdType="pubmed">29552440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo TW, Figueroa-Romero C, Hur J, Pacut C, Stoll E, Spring C, et al. Extracellular vesicles in serum and central nervous system tissues contain microRNA signatures in sporadic amyotrophic lateral sclerosis. Front Mol Neurosci. 2021;14:739016. doi: 10.3389/fnmol.2021.739016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.739016</ArticleId><ArticleId IdType="pmc">PMC8586523</ArticleId><ArticleId IdType="pubmed">34776863</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes C, Sequeira C, Barbosa M, Cunha C, Vaz AR, Brites D. Astrocyte regional diversity in ALS includes distinct aberrant phenotypes with common and causal pathological processes. Exp Cell Res. 2020;395:112209. doi: 10.1016/j.yexcr.2020.112209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2020.112209</ArticleId><ArticleId IdType="pubmed">32739211</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11:323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Sundaramoorthy V, Sultana JM, Yang S, Atkinson RA, Levina V, et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013;339:1335&#x2013;1338. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Primers. 2015;1:15005. doi: 10.1038/nrdp.2015.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2015.5</ArticleId><ArticleId IdType="pubmed">27188817</ArticleId></ArticleIdList></Reference><Reference><Citation>McColgan P, Tabrizi SJ. Huntington's disease: a clinical review. Eur J Neurol. 2018;25:24&#x2013;34. doi: 10.1111/ene.13413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13413</ArticleId><ArticleId IdType="pubmed">28817209</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol. 2009;11:219&#x2013;225. doi: 10.1038/ncb1830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1830</ArticleId><ArticleId IdType="pmc">PMC2757079</ArticleId><ArticleId IdType="pubmed">19151706</ArticleId></ArticleIdList></Reference><Reference><Citation>Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P, et al. Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons. Nat Neurosci. 2014;17:1064&#x2013;1072. doi: 10.1038/nn.3761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3761</ArticleId><ArticleId IdType="pubmed">25017010</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Dunlap JR, Andrews RB, Wetzel R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet. 2002;11:2905&#x2013;2917. doi: 10.1093/hmg/11.23.2905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.23.2905</ArticleId><ArticleId IdType="pubmed">12393802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicchetti F, Lacroix S, Cisbani G, Valli&#xe8;res N, Saint-Pierre M, St-Amour I, et al. Mutant huntingtin is present in neuronal grafts in Huntington disease patients. Ann Neurol. 2014;76:31&#x2013;42. doi: 10.1002/ana.24174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24174</ArticleId><ArticleId IdType="pubmed">24798518</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon I, Cicchetti F, Cisbani G, Lee S, Li E, Bae J, et al. Human-to-mouse prion-like propagation of mutant huntingtin protein. Acta Neuropathol. 2016;132:577&#x2013;592. doi: 10.1007/s00401-016-1582-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1582-9</ArticleId><ArticleId IdType="pmc">PMC5023734</ArticleId><ArticleId IdType="pubmed">27221146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Liu T, Im W, Kim M. Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington's disease in vitro model. Eur J Neurosci. 2016;44:2114&#x2013;2119. doi: 10.1111/ejn.13275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13275</ArticleId><ArticleId IdType="pubmed">27177616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y, Zhao T, Li XJ, Li S. Mutant Huntingtin inhibits &#x3b1;b-crystallin expression and impairs exosome secretion from astrocytes. J Neurosci. 2017;37:9550&#x2013;9563. doi: 10.1523/JNEUROSCI.1418-17.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1418-17.2017</ArticleId><ArticleId IdType="pmc">PMC5618269</ArticleId><ArticleId IdType="pubmed">28893927</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Koutras C, Donnelier J, Alshehri M, Fotouhi M, Girard M, et al. Neurons export extracellular vesicles enriched in cysteine string protein and misfolded protein cargo. Sci Rep. 2017;7:956. doi: 10.1038/s41598-017-01115-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-01115-6</ArticleId><ArticleId IdType="pmc">PMC5430488</ArticleId><ArticleId IdType="pubmed">28424476</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee ST, Im W, Ban JJ, Lee M, Jung KH, Lee SK, et al. Exosome-based delivery of miR-124 in a Huntington's disease model. J Mov Disord. 2017;10:45&#x2013;52. doi: 10.14802/jmd.16054.</Citation><ArticleIdList><ArticleId IdType="doi">10.14802/jmd.16054</ArticleId><ArticleId IdType="pmc">PMC5288667</ArticleId><ArticleId IdType="pubmed">28122430</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol. 2021;16:748&#x2013;759. doi: 10.1038/s41565-021-00931-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-021-00931-2</ArticleId><ArticleId IdType="pubmed">34211166</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu M, Lin Q, Huang L, Fu Y, Wang L, He S, et al. Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease. J Control Release. 2018;287:156&#x2013;166. doi: 10.1016/j.jconrel.2018.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2018.08.035</ArticleId><ArticleId IdType="pubmed">30165139</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE, et al. Extracellular vesicles as drug delivery systems: Why and how? Adv Drug Deliv Rev. 2020;159:332&#x2013;343. doi: 10.1016/j.addr.2020.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2020.04.004</ArticleId><ArticleId IdType="pubmed">32305351</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341&#x2013;345. doi: 10.1038/nbt.1807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1807</ArticleId><ArticleId IdType="pubmed">21423189</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper JM, Wiklander PB, Nordin JZ, Al-Shawi R, Wood MJ, Vithlani M, et al. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice. Mov Disord. 2014;29:1476&#x2013;1485. doi: 10.1002/mds.25978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25978</ArticleId><ArticleId IdType="pmc">PMC4204174</ArticleId><ArticleId IdType="pubmed">25112864</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonafede R, Scambi I, Peroni D, Potrich V, Boschi F, Benati D, et al. Exosome derived from murine adipose-derived stromal cells: neuroprotective effect on in vitro model of amyotrophic lateral sclerosis. Exp Cell Res. 2016;340:150&#x2013;158. doi: 10.1016/j.yexcr.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2015.12.009</ArticleId><ArticleId IdType="pubmed">26708289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Ban JJ, Kim KY, Jeon GS, Im W, Sung JJ, et al. Adipose-derived stem cell exosomes alleviate pathology of amyotrophic lateral sclerosis in vitro. Biochem Biophys Res Commun. 2016;479:434&#x2013;439. doi: 10.1016/j.bbrc.2016.09.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.09.069</ArticleId><ArticleId IdType="pubmed">27641665</ArticleId></ArticleIdList></Reference><Reference><Citation>Didiot MC, Hall LM, Coles AH, Haraszti RA, Godinho BM, Chase K, et al. Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing. Mol Ther. 2016;24:1836&#x2013;1847. doi: 10.1038/mt.2016.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2016.126</ArticleId><ArticleId IdType="pmc">PMC5112038</ArticleId><ArticleId IdType="pubmed">27506293</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Zald&#xed;var HM, Polakovicova I, Salas-Huenuleo E, Corval&#xe1;n AH, Kogan MJ, Yefi CP, et al. Extracellular vesicles through the blood-brain barrier: a review. Fluids Barriers CNS. 2022;19:60. doi: 10.1186/s12987-022-00359-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-022-00359-3</ArticleId><ArticleId IdType="pmc">PMC9310691</ArticleId><ArticleId IdType="pubmed">35879759</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien K, Ughetto S, Mahjoum S, Nair AV, Breakefield XO. Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep. 2022;39:110651. doi: 10.1016/j.celrep.2022.110651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.110651</ArticleId><ArticleId IdType="pmc">PMC9074118</ArticleId><ArticleId IdType="pubmed">35417683</ArticleId></ArticleIdList></Reference><Reference><Citation>Osorio-Querejeta I, Alberro A, Mu&#xf1;oz-Culla M, M&#xe4;ger I, Otaegui D. Therapeutic potential of extracellular vesicles for demyelinating diseases; challenges and opportunities. Front Mol Neurosci. 2018;11:434. doi: 10.3389/fnmol.2018.00434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00434</ArticleId><ArticleId IdType="pmc">PMC6265410</ArticleId><ArticleId IdType="pubmed">30532691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cone AS, Yuan X, Sun L, Duke LC, Vreones MP, Carrier AN, et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model. Theranostics. 2021;11:8129&#x2013;8142. doi: 10.7150/thno.62069.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.62069</ArticleId><ArticleId IdType="pmc">PMC8344012</ArticleId><ArticleId IdType="pubmed">34373732</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Zaldivar EE, Hern&#xe1;ndez-Sapi&#xe9;ns MA, Guti&#xe9;rrez-Mercado YK, Sandoval-&#xc1;vila S, Gomez-Pinedo U, M&#xe1;rquez-Aguirre AL, et al. Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease. Neural Regen Res. 2019;14:1626&#x2013;1634. doi: 10.4103/1673-5374.255978.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.255978</ArticleId><ArticleId IdType="pmc">PMC6557105</ArticleId><ArticleId IdType="pubmed">31089063</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu Z, et al. Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer's disease. Neurochem Res. 2018;43:2165-2177</Citation><ArticleIdList><ArticleId IdType="pubmed">30259257</ArticleId></ArticleIdList></Reference><Reference><Citation>Elia CA, Tamborini M, Rasile M, Desiato G, Marchetti S, Swuec P, et al. Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced a&#x3b2; plaque burden in early stages of a preclinical model of Alzheimer's disease. Cells. 2019;8:1059. doi: 10.3390/cells8091059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8091059</ArticleId><ArticleId IdType="pmc">PMC6770482</ArticleId><ArticleId IdType="pubmed">31510042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SS, Jia J, Wang Z. Mesenchymal stem cell-derived extracellular vesicles suppresses iNOS expression and ameliorates neural impairment in Alzheimer's disease mice. J Alzheimers Dis. 2018;61:1005&#x2013;1013. doi: 10.3233/JAD-170848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170848</ArticleId><ArticleId IdType="pubmed">29254100</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui GH, Guo HD, Li H, Zhai Y, Gong ZB, Wu J, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer's disease. Immun Ageing. 2019;16:10. doi: 10.1186/s12979-019-0150-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12979-019-0150-2</ArticleId><ArticleId IdType="pmc">PMC6515654</ArticleId><ArticleId IdType="pubmed">31114624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuyama K, Sun H, Sakai S, Mitsutake S, Okada M, Tahara H, et al. Decreased amyloid-&#x3b2; pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J Biol Chem. 2014;289:24488&#x2013;24498. doi: 10.1074/jbc.M114.577213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.577213</ArticleId><ArticleId IdType="pmc">PMC4148874</ArticleId><ArticleId IdType="pubmed">25037226</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuyama K, Sun H, Usuki S, Sakai S, Hanamatsu H, Mioka T, et al. A potential function for neuronal exosomes: sequestering intracerebral amyloid-&#x3b2; peptide. FEBS Lett. 2015;589:84&#x2013;88. doi: 10.1016/j.febslet.2014.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2014.11.027</ArticleId><ArticleId IdType="pubmed">25436414</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuda T, Tsuchiya R, Kosaka N, Yoshioka Y, Takagaki K, Oki K, et al. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep. 2013;3:1197. doi: 10.1038/srep01197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01197</ArticleId><ArticleId IdType="pmc">PMC3561625</ArticleId><ArticleId IdType="pubmed">23378928</ArticleId></ArticleIdList></Reference><Reference><Citation>Haney MJ, Klyachko NL, Zhao Y, Gupta R, Plotnikova EG, He Z, et al. Exosomes as drug delivery vehicles for Parkinson's disease therapy. J Control Release. 2015;207:18&#x2013;30. doi: 10.1016/j.jconrel.2015.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2015.03.033</ArticleId><ArticleId IdType="pmc">PMC4430381</ArticleId><ArticleId IdType="pubmed">25836593</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarmalavi&#x10d;i&#x16b;t&#x117; A, Tunaitis V, Pivorait&#x117; U, Venalis A, Pivori&#x16b;nas A. Exosomes from dental pulp stem cells rescue human dopaminergic neurons from 6-hydroxy-dopamine-induced apoptosis. Cytotherapy. 2015;17:932&#x2013;939. doi: 10.1016/j.jcyt.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2014.07.013</ArticleId><ArticleId IdType="pubmed">25981557</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HX, Liang FC, Gu P, Xu BL, Xu HJ, Wang WT, et al. Exosomes derived from mesenchymal stem cells repair a Parkinson's disease model by inducing autophagy. Cell Death Dis. 2020;11:288. doi: 10.1038/s41419-020-2473-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2473-5</ArticleId><ArticleId IdType="pmc">PMC7184757</ArticleId><ArticleId IdType="pubmed">32341347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AF. Extracellular vesicles and neurodegenerative diseases. J Neurosci. 2019;39:9269&#x2013;9273. doi: 10.1523/JNEUROSCI.0147-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0147-18.2019</ArticleId><ArticleId IdType="pmc">PMC6867808</ArticleId><ArticleId IdType="pubmed">31748282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>